Want to see PHIO full AI Analyst Report?
Phio Pharmaceuticals (PHIO) Stock Statistics & Valuation Metrics
Total Valuation
Phio Pharmaceuticals has a market cap or net worth of $9.58M. The enterprise value is $1.43M.
- Market Cap
- $9.58M
- Enterprise Value
- $1.43M
Share Statistics
Phio Pharmaceuticals has 11,951,632 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,951,632
- Owned by Insiders
- 9.95%
- Owned by Institutions
- 3.74%
Financial Efficiency
Phio Pharmaceuticals’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -43.80%.
- Return on Equity (ROE)
- -0.43
- Return on Assets (ROA)
- -0.40
- Return on Invested Capital (ROIC)
- -43.80%
- Return on Capital Employed (ROCE)
- -0.44
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.45M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Phio Pharmaceuticals is -0.64. Phio Pharmaceuticals’s PEG ratio is -0.01.
- PE Ratio
- -0.64
- PS Ratio
- 0.00
- PB Ratio
- 1.09
- Price to FCF
- -0.75
- Price to Operating Cash Flow
- -0.76
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Phio Pharmaceuticals had revenue of 0 and earned -8.70M in profits. Earnings per share was -1.45.
- Revenue
- 0
- Gross Profit
- -4.62M
- Operating Income
- -9.22M
- Pretax Income
- -8.70M
- Net Income
- -8.70M
- EBITDA
- -8.70M
- Earnings Per Share (EPS)
- -1.45
Cash Flow
In the last 12 months, operating cash flow was -12.40M and capital expenditures 0, giving a free cash flow of -12.40M billion.
- Operating Cash Flow
- -12.40M
- Free Cash Flow
- -12.40M
- Free Cash Flow per Share
- -1.06
Dividends & Yields
Phio Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -133.17%
- Earnings Yield
- -156.63%
Stock Price Statistics
- Beta
- 2.01
- 52-Week Price Change
- -45.88%
- 50-Day Moving Average
- 0.97
- 200-Day Moving Average
- 1.09
- Relative Strength Index (RSI)
- 32.97
- Average Volume (3m)
- 124.09K
Important Dates
Phio Pharmaceuticals upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Phio Pharmaceuticals as a current ratio of 49.37, with Debt / Equity ratio of 0.00%
- Current Ratio
- 49.37
- Quick Ratio
- 49.37
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.42
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Phio Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Phio Pharmaceuticals EV to EBITDA ratio is 0.12, with an EV/FCF ratio of 0.10.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.12
- EV to Free Cash Flow
- 0.10
- EV to Operating Cash Flow
- 0.10
Balance Sheet
Phio Pharmaceuticals has $10.61M in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.61M billion.
- Cash & Marketable Securities
- $10.61M
- Total Debt
- $0.00
- Net Cash
- $10.61M
- Net Cash Per Share
- $0.89
- Tangible Book Value Per Share
- $0.74
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Phio Pharmaceuticals is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $14.00
- Price Target Upside
- 1647.82% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 43.66%
Scores
- Smart Score
- ―
- AI Score
- 43
